National Institute on Drug Abuse Notice of May Advisory Council on Drug Abuse Meeting, 22823 [2014-09285]

Download as PDF Federal Register / Vol. 79, No. 79 / Thursday, April 24, 2014 / Notices Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel, 2014–10 NIBIB K and R13 Review. Date: July 2, 2014. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Suite 957, Bethesda, MD 20892, 301–496–4773, zhour@mail.nih.gov. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–09424 Filed 4–23–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse Notice of May Advisory Council on Drug Abuse Meeting Pursuant to the NIH Reform Act of 2006 (42 U.S.C. Sec. 281(d)(4)), notice is hereby given that the National Institute on Drug Abuse (NIDA) will host a meeting to enable public discussion on the Institute’s proposal to reorganize its extramural program in establishment of a Division of Extramural Research. The proposal seeks to clearly delineate functions and streamline the services provided within the Office of the Director, as well as capitalize on emerging scientific opportunities, while reducing barriers to scientific and interdisciplinary collaboration. SUMMARY: This public meeting will take place on May 7, 2014 with attendance limited to space available. Any interested person may file written comments by sending an email to NIDADERComment@mail.nih.gov, by May 12, 2014. The statement should include the individual’s name, contact information and, when applicable, professional affiliation. ADDRESSES: Neuroscience Center, Conference Rooms C & D, 6001 Executive Boulevard, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Dave Daubert, Deputy Executive Officer, National Institute on Drug Abuse, Office of the Director, 6001 Executive Boulevard, NSC Building, Room 5274, Bethesda, MD 20892, 301–402–1652, daubert@nih.gov. pmangrum on DSK3VPTVN1PROD with NOTICES DATES: VerDate Mar<15>2010 14:19 Apr 23, 2014 Jkt 232001 Members of the public wishing to attend must RSVP to the contact person on this notice by May 5, 2014. NIH has instituted stringent procedures for entrance onto the NIH campus and constituent facilities. Visitors will be asked to show one form of identification (for example a government-issued photo ID, valid driver’s license, or passport) and to state the purpose of their visit. Additionally, individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person by the deadline provided above in advance of the meeting. Individuals will also be able to view the meeting via NIH Videocast. Please go to the following link for Videocast access instructions at: https:// videocast.nih.gov/faq/#setup. A portion of this meeting will be closed to the public. Information is available on the Institute’s Web site, https://www.drugabuse.gov/news-events/ meetings-events/2014/05/nationaladvisory-council-drug-abuse, where details on the agenda and any additional information for the meeting will be posted when available. A portion of the agenda will include: A report by the Director, NIDA and a public discussion on the proposed reorganization plans for NIDA extramural program. SUPPLEMENTARY INFORMATION: Dated: April 17, 2014. Nora Volkow, Director, National Institute on Drug Abuse, National Institutes of Health. [FR Doc. 2014–09285 Filed 4–23–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 22823 Name of Committee: National Institute on Aging Special Emphasis Panel; Juvenile Protective Factor (JPF). Date: May 22, 2014. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Bita Nakhai, Ph.D., Scientific Review Branch, National Institute On Aging, Gateway Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–402–7701, nakhaib@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: April 21, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–09352 Filed 4–23–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. E:\FR\FM\24APN1.SGM 24APN1

Agencies

[Federal Register Volume 79, Number 79 (Thursday, April 24, 2014)]
[Notices]
[Page 22823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09285]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse Notice of May Advisory Council 
on Drug Abuse Meeting

SUMMARY: Pursuant to the NIH Reform Act of 2006 (42 U.S.C. Sec. 
281(d)(4)), notice is hereby given that the National Institute on Drug 
Abuse (NIDA) will host a meeting to enable public discussion on the 
Institute's proposal to reorganize its extramural program in 
establishment of a Division of Extramural Research. The proposal seeks 
to clearly delineate functions and streamline the services provided 
within the Office of the Director, as well as capitalize on emerging 
scientific opportunities, while reducing barriers to scientific and 
interdisciplinary collaboration.

DATES: This public meeting will take place on May 7, 2014 with 
attendance limited to space available. Any interested person may file 
written comments by sending an email to NIDADERComment@mail.nih.gov, by 
May 12, 2014. The statement should include the individual's name, 
contact information and, when applicable, professional affiliation.

ADDRESSES: Neuroscience Center, Conference Rooms C & D, 6001 Executive 
Boulevard, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Dave Daubert, Deputy Executive 
Officer, National Institute on Drug Abuse, Office of the Director, 6001 
Executive Boulevard, NSC Building, Room 5274, Bethesda, MD 20892, 301-
402-1652, daubert@nih.gov.

SUPPLEMENTARY INFORMATION: Members of the public wishing to attend must 
RSVP to the contact person on this notice by May 5, 2014. NIH has 
instituted stringent procedures for entrance onto the NIH campus and 
constituent facilities. Visitors will be asked to show one form of 
identification (for example a government-issued photo ID, valid 
driver's license, or passport) and to state the purpose of their visit. 
Additionally, individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the contact person by the deadline 
provided above in advance of the meeting.
    Individuals will also be able to view the meeting via NIH 
Videocast. Please go to the following link for Videocast access 
instructions at: https://videocast.nih.gov/faq/#setup.
    A portion of this meeting will be closed to the public. Information 
is available on the Institute's Web site, https://www.drugabuse.gov/news-events/meetings-events/2014/05/national-advisory-council-drug-abuse, where details on the agenda and any additional information for 
the meeting will be posted when available. A portion of the agenda will 
include: A report by the Director, NIDA and a public discussion on the 
proposed reorganization plans for NIDA extramural program.

    Dated: April 17, 2014.
Nora Volkow,
Director, National Institute on Drug Abuse, National Institutes of 
Health.
[FR Doc. 2014-09285 Filed 4-23-14; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.